Abeona Therapeutics Wts





Please Login or Register

Login|Register FREE

Stock Price
Open: 15.00
Prev. Close: 15.85
Low/Hi: 13.75 - 15.00
52-Week: 2.50 - 17.56
Equity: 7,757
90-Day Avg: 3,333
Todays Stock Vol: 163.5
20-Day (HV): 81.9
52-Week (HV): 141.7
Div. Yield:
Stock Info
Type: Warrant
Sector: N/A
Industry: N/A


Abeona Therapeutics, Inc. develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona's lead programs are AB0-101 (AAV9 NAGLU) and ABO-102 (scAAV9 SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA) in collaboration with patient advocate groups, researchers and clinicians, anticipated to commence clinical trials in 2015. They are also developing ABO-201 (scAAV9 CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV LK19 FANCC) for Fanconi anemia (FA) disorder using a novel CRISPR/Cas9-based gene editing approach to gene therapy program for rare blood diseases. In addition are also developing rare plasma protein therapies including SDF Alpha (alpha-1 protease inhibitor) for inherited COPD using our proprietary SDF (Salt Diafiltration) ethanol-free process.
Primary Exchange: NASDAQ

Wait, Before You Leave...

Receive Anticipated Price Moves into Earnings

Enter your email address below to receive FREE daily information about expected earnings moves and upcoming earnings.
Market Chameleon